<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04249791</url>
  </required_header>
  <id_info>
    <org_study_id>Uterine Transplant</org_study_id>
    <nct_id>NCT04249791</nct_id>
  </id_info>
  <brief_title>Laparoscopic-robotic Hysterectomy for Uterine Transplantation in Live-donor Patient.</brief_title>
  <acronym>transplant</acronym>
  <official_title>Feasibility Assessment of Assisted Laparoscopic-robotic Hysterectomy for Uterine Transplantation in Live-donor Patient. Description of the Donor and Recipient Surgical Technique.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barretos Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Barretos Cancer Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, there is no standard and indicated standard access route for uterine removal in
      the uterine transplant donor patient. The aim of the study is to show the feasibility of
      performing this procedure by replicating in our center the results found in other recent
      studies and to try to reduce the surgery time for both the donor and recipient patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Few cases have been performed worldwide by laparotomic and, more recently, laparoscopic and
      assisted robotic access pathways. This is a clinical trial with 6 participants (3 donors and
      3 recipients) to investigate the feasibility of an assisted laparoscopic-robotic surgical
      access route for uterine removal in the donor patient in uterine transplants. In the
      receiving patient, conventional surgery (midline incision) will be performed for uterine
      transplantation and vascular anastomoses.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2019</start_date>
  <completion_date type="Anticipated">June 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 25, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>transplant sucess rate</measure>
    <time_frame>2 years after transplantation</time_frame>
    <description>Assessed by records from Barretos Cancer Hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Live births after uterus transplantion</measure>
    <time_frame>2 years after transplantation</time_frame>
    <description>Assessed by records from Barretos Cancer Hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>2 years after transplantation</time_frame>
    <description>Assessed by records from Barretos Cancer Hospital</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Uterine Anomaly</condition>
  <arm_group>
    <arm_group_label>Uterus Transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo transplantation of the uterus from live donor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transplantation of the uterus from live donor.</intervention_name>
    <description>Laparoscopic-robotic hysterectomy for uterine transplantation in live-donor patient.</description>
    <arm_group_label>Uterus Transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Desire for uterine transplantation as a donor of the uterus (with family relationship
             with the donor patient);

          -  At least one pregnancy before

        Exclusion Criteria:

          -  comorbidities that contraindicate a surgical procedure

          -  Women who do not understand the study;

          -  Women subject to the regime that determines significant vulnerability to the
             participant (eg prisoners, indigenous, etc.)

          -  ABO blood test mismatch between donor and recipient patient.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MARCELO DE A VIEIRA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barretos Cancer Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MARCELO DE A VIEIRA, MD</last_name>
    <phone>+ 55 1733216600</phone>
    <phone_ext>7130</phone_ext>
    <email>mvieiraonco@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>MARCELO DE A VIEIRA, MD</last_name>
    <phone>+55 1733216600</phone>
    <phone_ext>7130</phone_ext>
    <email>mvieiraonco@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Barretos Cancer Hospital</name>
      <address>
        <city>Barretos</city>
        <state>São Paulo</state>
        <zip>14784400</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcelo A Vieira, MD</last_name>
      <phone>+551733216600</phone>
      <phone_ext>7130</phone_ext>
      <email>mvieiraonco@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>January 7, 2020</study_first_submitted>
  <study_first_submitted_qc>January 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2020</study_first_posted>
  <last_update_submitted>January 29, 2020</last_update_submitted>
  <last_update_submitted_qc>January 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>uterine transplant</keyword>
  <keyword>robotic surgery</keyword>
  <keyword>donor</keyword>
  <keyword>recipient</keyword>
  <keyword>uterine anomaly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

